Welcome to the Oncomine Blog
Healthcare Economic Analysis Makes Case for In-house NGS
08/07/2023 |
Education
Next-generation sequencing (NGS) has become an increasingly important tool for identifying molecular biomarkers that can help guide treatment...
-
Evaluating the Oncomine Myeloid Assay GX for Detection of Key Variants
Dr. Yi Ding of Geisinger Medical Laboratories recently presented at the 2020 Association of Molecula... -
What is Comprehensive Genomic Profiling & is it the Right Solution for You?
What is comprehensive genomic profiling? Comprehensive genomic profiling, or CGP, is the simultaneou... -
The Importance of Detecting Copy Number Variants (CNVs) in the Cancer Genome
Structural variants in the cancer genome Gene amplification (copy number gain) and deletion (copy nu... -
Breakthrough Device Designation for Oncomine Dx Precision Test Provides Insights into Brain Tumors Fueled by a Common Genetic Mutation
Philip Scard knew immediately and intimately that the June 15 news release from Thermo Fisher Scient... -
The Impact of NGS in Hematology-Oncology
In aggressive forms of cancer such as acute myeloid leukemia (AML), accurate diagnosis is needed as ... -
The OncomineWorld Experience from Behind the Curtain
BACKGROUND: There is little to no point in saying that we are all living in an unprecedented time, b... -
Comprehensive Biomarker Testing Reveals RET Alteration to Change Course of NSCLC Patient’s Treatment Options and Survival Outcome
It’s been a tough road for Melissa Crouse, sometimes almost deadly. She had a lobe of her left lung ... -
Building a Case for In-House Next Generation Sequencing
Diagnostics lab team demonstrates how insourcing NGS makes sound financial sense and helps deliver c... -
Q2 Solutions Eyes Genexus System as its Game-Changing Solution for Global Clinical Trial Services
When it comes to supporting clinical trials, having a global footprint is simply not enough for cont...